EuroFlow Standardisation: A Shared Instrument Setting Is Only One Part of Transfer

The 2012 EuroFlow study combines instrument settings and immunophenotyping protocols. Use its workflow perspective to define what must be checked when transferring an assay.

Transfer begins with a list of what changed

Two laboratories can use similar instrument settings while producing measurements that differ for reasons elsewhere in the workflow. A transfer review should therefore begin with the specimen, preparation, reagents and analysis as well as the cytometer.

What the historical EuroFlow study addresses

Kalina and colleagues' 2012 Leukemia article develops standardisation of flow cytometer settings and immunophenotyping protocols for an eight-colour approach. Its scope connects instrument configuration and quality checks with sample preparation and staining.

The study provides a historical workflow standardisation example. It does not automatically validate a new spectral platform, an expanded panel or a locally modified clinical assay. The article below is a transfer-planning discussion, not a new interlaboratory comparison.

Original CFCM conceptual checklist: Define the workflow; Locate the change; Verify intended use. No patient data or reproduced source figure. — Original CFCM conceptual diagram. Educational synthesis; not clinical validation.

Build a change inventory

For a local planning exercise, place the source workflow and proposed receiving workflow side by side. Identify differences in specimen handling, reagent identity, preparation steps, instrument configuration and analysis. Mark which differences have supporting evidence and which remain assumptions.

Do not reduce this inventory to a manufacturer or model name. The question is which part of the measurement a change could affect. A reagent modification may require different evidence from a change in a reporting calculation, even when both are described as a minor update.

Make acceptance criteria specific to the transfer

Choose the specimens and comparisons that can challenge the intended claim, including difficult cases appropriate to the assay. Record what constitutes an acceptable result and how exceptions will be handled before examining the transfer data. A generic instrument QC pass should not stand in for all of these decisions.

Keep historical publication evidence, local verification and clinical interpretation in separate records. Reproducing one part of an established workflow is useful information, but the transfer conclusion should name the complete configuration and intended use that were actually evaluated. These planning suggestions are original educational analysis; no local assay was tested for this article.

Daily Learning Pill

Standardisation concerns a connected workflow. State which parts match, which changed and what evidence supports the transfer.

Explore CFCM troubleshooting and resources. Original ChatGPT/Codex educational analysis, without independent scientific review or clinical certification.